QUDEXY
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $18.15 | 1 | 1 |
| 2022 | $6.06 | 1 | 1 |
| 2021 | $12,321 | 44 | 28 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $11,592 | 5 | 93.9% |
| Food and Beverage | $577.47 | 40 | 4.7% |
| Consulting Fee | $175.00 | 1 | 1.4% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 4 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF QUDEXY(R) XR IN THE PREVENTION OF MIGRAINE IN CHILDREN 6 TO 11 YEARS OF AGE | UPSHER-SMITH LABORATORIES LLC | $11,592 | 1 |
Top Doctors Receiving Payments for QUDEXY
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Jackson, MS | $10,242 | 4 |
| , MD | Neurology with Special Qualifications in Child Neurology | Philadelphia, PA | $1,350 | 1 |
| , MD | Pediatrics | Aurora, CO | $175.00 | 1 |
| , FNP-C | Family | Dallas, TX | $47.40 | 4 |
| , FNP | Family Medicine | Dallas, TX | $47.39 | 4 |
| , PA-C | Medical | Irwin, PA | $34.42 | 1 |
| , DO | Internal Medicine | Dallas, TX | $32.57 | 1 |
| , M.D | Neurology | Richardson, TX | $23.71 | 1 |
| , MD | Neurology | Dallas, TX | $23.61 | 3 |
| , M.D | Neurology | Dallas, TX | $23.61 | 3 |
| , NP | Family | Dallas, TX | $23.60 | 3 |
| , M.D | Internal Medicine | Greenville, AL | $19.58 | 1 |
| , M.D | Neurology with Special Qualifications in Child Neurology | Cincinnati, OH | $18.15 | 1 |
| , ARNP | Family | Navarre, FL | $17.42 | 1 |
| , M.D | Family Medicine | Navarre, FL | $17.41 | 1 |
| , M.D | Family Medicine | Daphne, AL | $16.80 | 1 |
| , M.D | Internal Medicine | Mobile, AL | $16.80 | 1 |
| , M.D | Neurology | Mobile, AL | $16.80 | 1 |
| , M.D | Ophthalmology | Daphne, AL | $16.79 | 1 |
| , M.D | Internal Medicine | Mobile, AL | $16.79 | 1 |
| , P.A | Medical | Plano, TX | $16.39 | 1 |
| , PA | Family Medicine | Carrollton, TX | $16.39 | 1 |
| , MD | Family Medicine | Plano, TX | $16.39 | 1 |
| William Calley | — | Plano, TX | $16.39 | 1 |
| , APRN | Nurse Practitioner | Crestview Hills, KY | $16.18 | 1 |
Manufacturing Companies
- UPSHER-SMITH LABORATORIES LLC $12,345
Product Information
- Type Drug
- Total Payments $12,345
- Total Doctors 30
- Transactions 46
About QUDEXY
QUDEXY is a drug associated with $12,345 in payments to 30 healthcare providers, recorded across 46 transactions in the CMS Open Payments database. The primary manufacturer is UPSHER-SMITH LABORATORIES LLC.
Payment data is available from 2021 to 2023. In 2023, $18.15 was paid across 1 transactions to 1 doctors.
The most common payment nature for QUDEXY is "Unspecified" ($11,592, 93.9% of total).
QUDEXY is associated with 1 research study, including "A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 4 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF QUDEXY(R) XR IN THE PREVENTION OF MIGRAINE IN CHILDREN 6 TO 11 YEARS OF AGE" ($11,592).